| Sarcoidosis |
1 |
1 |
| Corticosteroids |
0 |
0.35 |
| Dermatoses |
0 |
0.35 |
| Crohn Disease |
0 |
0.9 |
| Biopsy |
0 |
0.26 |
| Eosinophilic Fasciitis |
0 |
0.95 |
| Surgery |
0 |
0.26 |
| Intestinal Surgery |
0 |
0.25 |
| Muscle Biopsy |
0 |
0.25 |
| Vasculitis |
0 |
0.24 |
| Non-Hodgkin Lymphoma (NHL) |
0 |
0.22 |
| Thyroid Disease |
0 |
0.21 |
| Central Nervous System |
0 |
0.17 |
| Child |
0 |
0.17 |
| Heart |
0 |
0.17 |
| Lupus |
0 |
0.17 |
| Nodule |
0 |
0.17 |
| Radiation Therapy |
0 |
0.17 |
| Skin Lesion |
0 |
0.17 |
| Topical Therapy |
0 |
0.17 |
| Laser |
0 |
0.15 |
| Systemic Lupus Erythematosus |
0 |
0.15 |
| Cornea and External Disease |
0 |
0.13 |
| Uveitis |
0 |
0.13 |
| Graft Versus Host Disease |
0 |
0.12 |
| Tumor Necrosis Factor-Alpha |
0 |
0.12 |
| Anaphylaxis |
0 |
0.11 |
| Graft Versus Host Disease and Transplant Complications |
0 |
0.11 |
| Stem Cell Research and Therapy |
0 |
0.11 |
| Anterior Uveitis |
0 |
0.09 |
| Blood |
0 |
0.09 |
| Bone |
0 |
0.09 |
| Burnout |
0 |
0.09 |
| Cervical Region |
0 |
0.09 |
| Chemotherapy |
0 |
0.09 |
| Clinical Guidelines |
0 |
0.09 |
| Cryotherapy |
0 |
0.09 |
| Eosinophilia |
0 |
0.09 |
| Erythema Nodosum |
0 |
0.09 |
| Exercise |
0 |
0.09 |
| Face |
0 |
0.09 |
| Gastrointestinal Disease |
0 |
0.09 |
| Graft |
0 |
0.09 |
| Granuloma Annulare |
0 |
0.09 |
| Hematological Disorders |
0 |
0.09 |
| Intravenous |
0 |
0.09 |
| Kentucky |
0 |
0.09 |
| Lymph Node |
0 |
0.09 |
| Lymphadenopathy |
0 |
0.09 |
| Lymphoma |
0 |
0.09 |
| Magnetic Resonance Imaging |
0 |
0.09 |
| Muscle |
0 |
0.09 |
| Nose |
0 |
0.09 |
| Orbit |
0 |
0.09 |
| Pernio |
0 |
0.09 |
| Physical Therapy |
0 |
0.09 |
| Respiratory Tract |
0 |
0.09 |
| Scalp |
0 |
0.09 |
| Statins |
0 |
0.09 |
| Tumor |
0 |
0.09 |
| Xanthelasma |
0 |
0.09 |
| Young Adult |
0 |
0.09 |
| Hemodialysis |
0 |
0.08 |
| Hypothyroidism |
0 |
0.08 |
| Lipids Management |
0 |
0.08 |
| Physical Medicine and Rehabilitation (PMR) |
0 |
0.08 |
| Skin and Soft Tissue Infection |
0 |
0.08 |